Finally, imaging features specific to glioma subtypes and molecular genetic features, such as ATRX and 1p/19q status (31), as well as metabolomics indicators like phenylalanine, 2-glyceryl phosphate, lysine, and N-acetylaspartic acid (NAA) (32), were not included in this study. The gene discussed is ATRX; the disease is central nervous system cancer.